North China Pharmaceutical Group Co., Ltd. is the largest pharmaceutical enterprise in China, located in Shijiazhuang, the capital of Hebei Province. The company's predecessor, North China Pharmaceutical Factory, was a national key construction project during the First Five-Year Plan period. The 156 key project aided by the former Soviet Union consists of an antibiotic factory, a starch factory and a medical glass factory imported from the former Democratic Republic of Germany.
Construction started in June, 1953, with a total investment of 75.88 million yuan, and it was all put into production in June. Since its establishment more than 50 years ago, Huayao has developed steadily from a factory with a single property right structure to an enterprise group with more than 30 subsidiaries and diversified investors.
The establishment of North China Pharmaceutical Factory initiated the history of mass production of antibiotics in China and ended the history of China's dependence on imported penicillin and streptomycin.
Extended data:
The main products are raw materials and preparations of antibiotics and health products such as penicillin, streptomycin, oxytetracycline, lincomycin, semi-synthetic penicillin and cephalosporin, as well as nearly 100 varieties of VB 12, medical glass products, organic solvents, starch and sugar.
Huabei Pharmaceutical Co., Ltd. is a joint stock limited company invested by the former Huabei Pharmaceutical Factory (now Huabei Pharmaceutical Group Co., Ltd.) with all its production and operation assets, and was established by issuing shares in August 1992. 1994 65438+1October 14. The company's shares are listed on the Shanghai Stock Exchange.
Baidu encyclopedia-north China pharmaceutical co., ltd.